2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine
Modify Date: 2024-01-29 18:58:56
2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine structure
|
Common Name | 2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine | ||
|---|---|---|---|---|
| CAS Number | 622379-83-3 | Molecular Weight | 585.56 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C31H27N3O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione |
|---|---|
| Synonym | More Synonyms |
| Description | 2',3',5'-Tri-O-benzoyl-2'-beta-C-methyl-6-azauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C31H27N3O9 |
| Molecular Weight | 585.56 |
| Exact Mass | 571.159058 |
| LogP | 6.05 |
| Index of Refraction | 1.645 |
| 1,2,4-Triazine-3,5(2H,4H)-dione, 2-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)- |
| 2-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione |